In the BioHarmony Drug Report Database

"Preview" Icon

Argatroban

Argatroban (argatroban) is a small molecule pharmaceutical. Argatroban was first approved as Argatroban on 2000-06-30. It is used to treat thrombocytopenia and thromboembolism in the USA. The pharmaceutical is active against prothrombin. Argatroban’s patent is valid until 2027-09-26 (FDA).

 

Trade Name

 

Argatroban
 

Common Name

 

argatroban
 

ChEMBL ID

 

CHEMBL1166
 

Indication

 

thrombocytopenia, thromboembolism
 

Drug Class

 

Antithrombotics (thromboxane A2 receptor antagonists)

Image (chem structure or protein)

Argatroban structure rendering